Home LiteratureArticle Details
PMID: 1698253 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Regulation of calcium current by low-Km cyclic AMP phosphodiesterases in cardiac cells.

Molecular pharmacology ·Vol. 38 ·No. 3 ·1990-09-00 ·Pages 426-33

Fischmeister R, Hartzell HC

Abstract

The voltage-gated Ca2+ current (ICa) in cardiac myocytes is regulated by cAMP-dependent phosphorylation. Although the regulation of ICa via mechanisms involving modulation of cAMP synthesis is well understood, the regulation of cAMP degradation has been less thoroughly investigated. The goal of the present study was to investigate the participation of different subclasses of cAMP phosphodiesterase (PDE) in regulating cAMP-dependent phosphorylation of Ca2+ channels in frog ventricular myocytes. Cardiomyocytes were isolated enzymatically and mechanically and were patch-clamped using the whole-cell configuration of the patch-clamp technique. The effects of various low-Km cAMP PDE inhibitors on ICa were examined. None of the inhibitors tested [milrinone, indolidan, 1-methyl 3-isobutyl xanthine (MIX), rolipram, or Ro 20-1724] were able to elevate ICa in the absence of elevated cAMP, although they all increased ICa in the presence of submaximal levels of cAMP. This result suggests that these compounds do not act directly on Ca2+ channels but rather modulate cAMP degradation. Half-maximal effects were observed with 1.4 microM milrinone and 3.4 microM MIX. Milrinone was effective when applied from either the extracellular or intracellular surface, whereas MIX was effective only when applied from the extracellular solution. In the presence of internal cGMP, which stimulates the cGMP-stimulated PDE, the low-Km cAMP PDE inhibitors had no effect on ICa, whereas high concentrations of MIX, which inhibit the cGMP-stimulated PDE, increased ICa. This would support the hypothesis that cGMP-stimulated PDE either has a much stronger capacity to hydrolyze cAMP or is more efficiently coupled to Ca2+ channels than the low-Km cAMP PDEs.

MeSH Terms
1-Methyl-3-isobutylxanthine/pharmacology 3',5'-Cyclic-AMP Phosphodiesterases/physiology Animals Calcium Channels/drug effects,physiology Cyclic AMP/pharmacology Cyclic GMP/pharmacology Dose-Response Relationship, Drug In Vitro Techniques Milrinone Myocardium/metabolism Phosphodiesterase Inhibitors/pharmacology Pyridones/pharmacology Rana esculenta
Chemicals
Calcium Channels Phosphodiesterase Inhibitors Pyridones Cyclic AMP 3',5'-Cyclic-AMP Phosphodiesterases Cyclic GMP Milrinone 1-Methyl-3-isobutylxanthine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Fischmeister R
Laboratoire de Physiologie Cellulaire Cardiaque, INSERM U-241, Université de Paris-Sud, Orsay, France.
Hartzell H C
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
1990-09-00
Pages
426-33
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NHLBI NIH HHS · HL21195 · United States
NHLBI NIH HHS · HL27385 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]